 Comparison levels anticoagulant therapy patients substitute heart valves cardiac valve replacement patients groups aspirin mg dipyridamole mg oral anticoagulant acenocoumarol Sintrom international normalized ratio group group groups thromboembolic hemorrhagic complications Final evaluation patients follow-up months group months/patient months group months/patient frequency thromboembolism equal groups transient ischemic attack group rate patient-years transient ischemic attacks group rate patient-years statistical difference complications groups patients group rate patient-years incidence episode years treatment patients group rate patient-years incidence episode years treatment international normalized ratio ratio confers good protection thromboembolism oral anticoagulant therapy platelet function-inhibiting drugs patients mechanical substitute heart valves